Bruker Corp (BRKR) Stock Price, Quote & News

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 663 3660

Fax: 978 663 5585

Website: www.bruker.com

Address:

40 Manning Road, Billerica, United States

YoloSqueeze Jun. 3 at 2:46 PM

$SMCI if we wanted to move, we would be doing what $BRKR is doing

0 · Reply

DavyDaveCharts May. 28 at 3:54 PM

$BRKR 18% in 7 days.

0 · Reply

DavyDaveCharts May. 21 at 9:13 PM

$BRKR monthly: nice bounce from the bullish imbalance. looking at 56 as a draw on liquidity. Momentum indicators are bullish.

0 · Reply

stockpicker63 May. 6 at 6:58 PM

Watch $BRKR

0 · Reply

StocktwitsEarnings May. 6 at 10:37 AM

$BRKR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.02 down -81.82% YoY • Reported revenue of $823.4M up 2.75% YoY • Bruker reconfirms FY2026 guidance, expecting revenues of $3.57B, an increase of 4% to 5% year-over-year, with 1% to 2% organic growth. Non-GAAP EPS is projected to be $2.10 to $2.15, up 15% to 17% year-over-year.

0 · Reply

Ren_Stimpy May. 1 at 11:59 AM

$STIM $BRKR $BIO $AHCO $ENOV this is just a few examples of companies in the medical device industry that sold more of their shares than they currently have. Add up the percentage of institutional, insiders and shares shorted. All well over 💯 percent!! How will the short sellers buy back shares that don’t exist? I think short sellers are in trouble of losing big betting against this industry.

0 · Reply

CHItraders Apr. 17 at 1:15 PM

$BRKR Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

0 · Reply

SuperGreenToday Mar. 31 at 2:44 AM

$BRKR Share Price: $34.31 Contract Selected: Sep 18, 2026 $35 Calls Buy Zone: $4.17 – $5.15 Target Zone: $7.07 – $8.65 Potential Upside: 60% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

topstockalerts Mar. 17 at 5:18 PM

Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides. The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell. GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement. $BRKR $TXG

2 · Reply

BillionerOfKing Mar. 4 at 7:26 PM

$BRKR Current Stock Price: $38.94 Contracts to trade: $40.0 BRKR Mar 20 2026 Call Entry: $1.15 Exit: $2.09 ROI: 81% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Bruker Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 7:00 AM EDT - 13 hours ago

Market Cap	8.72B
Revenue (ttm)	3.44B
Net Income (ttm)	-8.60M
EPS (ttm)	N/A
PE Ratio	34.99
Forward PE	27.57
Profit Margin	-0.25%
Debt to Equity Ratio	0.68

Volume	5,790,200
Avg Vol	2,260,700
Day's Range	N/A - N/A
Shares Out	152.23M
Stochastic %K	99%
Beta	1.31
Analysts	Strong Sell
Price Target	$49.15